Your session is about to expire
← Back to Search
Rosuvastatin for Osteoporosis (RoBaCO Trial)
RoBaCO Trial Summary
This trial is testing whether a drug called Rosuvastatin can help to reduce bone loss and inflammation in people with long-term spinal cord injuries.
- Osteoporosis
- Spinal Cord Injury
- Metabolic Syndrome
RoBaCO Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowRoBaCO Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.RoBaCO Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Does this clinical trial have an age limit?
"This trial includes a minimum age limit of 18 and participants must not be older than 60."
Has Rosuvastatin been federally authorized for general use?
"Rosuvastatin's safety is estimated to be a 2. This means that while there is some evidence suggesting that it is safe, there is no data yet confirming its efficacy."
What do we know about Rosuvastatin from other research projects?
"Development of Rosuvastatin began in 2009 at the University of Ioannina Medical School. To date, there are 762 completed trials with 42 active clinical trials ongoing. Many of these studies taking place in Toronto, Canada."
What are patients generally taking Rosuvastatin for?
"Rosuvastatin is a popular medication used to combat hypertriglyceridemias. However, this drug can also be helpful for patients suffering from cardiovascular disease (cvd), cardiovascular events, and those that have undergone cardiovascular surgeries."
Could I possibly take part in this examination?
"Up to 8 individuals aged 18-60 who have recently (within 2 years) suffered a spinal cord injury will be enrolled in this trial. Other important requirements for participants include having a working telephone and being able to commit to attending study visits."
Are there any available patients slots for this clinical trial?
"The trial in question, which can be found on clinicaltrials.gov, is not recruiting patients at this time. This particular study was last updated on October 19th 2021 and was first posted February 26th 2018. There are 692 other trials that are currently looking for participants."
How many individuals are being asked to participate in this research?
"Currently, this particular trial is not enrolling new patients. It was originally posted on February 26th, 2018 and last updated on October 19th, 2021. There are 650 trials for spinal cord injuries and 42 studies for Rosuvastatin currently recruiting participants."
Share this study with friends
Copy Link
Messenger